{
  "nctId": "NCT07173140",
  "briefTitle": "Renal Tumour Imaging Using MRI",
  "officialTitle": "A Two Site Pilot Study of Functional and Microstructural Imaging Using Magnetic Resonance Imaging in Patients With Renal Tumours",
  "protocolDocument": {
    "nctId": "NCT07173140",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2024-03-21",
    "uploadDate": "2025-09-08T06:37",
    "size": 888923,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT07173140/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NON_RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 30,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2024-11-20",
    "completionDate": "2025-09-30",
    "primaryCompletionDate": "2025-06-19",
    "firstSubmitDate": "2025-08-18",
    "firstPostDate": "2025-09-15"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n1. Aged 18 and over\n2. Confirmed renal tumour â‰¤ 7 cm planned for surgical resection\n3. Willing and able to provide written informed consent\n4. Able to lie supine for the duration of an MRI\n\nExclusion Criteria:\n\n1. Contraindication to MRI e.g., cardiac pacemaker\n2. Contraindication to MR contrast agents\n3. Pregnancy\n4. Breastfeeding\n5. Deranged renal function (eGFR \\<30) in the last three months.\n6. Previous treatment of the renal tumour e.g., ablation, radiotherapy",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Diagnostic accuracy of proton density fat fraction (PDFF) to differentiate different histological subtypes of renal tumours.",
        "description": "PDFF mean values will be calculated for each tumour in arms 2 and 3. Following surgery the means for each histological subtype will be calculated and tested for statistical significance.",
        "timeFrame": "1 year"
      },
      {
        "measure": "Repeatability of proton density fat fraction (PDFF) measurements.",
        "description": "Participants in arm 3 will undergo repeat scanning with a short time interval between scans. The repeatability of PDFF measurements will be assessed using within subject standard deviation, repeatability coefficients and Bland-Altman analysis.",
        "timeFrame": "1 year"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 0,
      "exclusionCount": 0,
      "totalCount": 0
    },
    "endpoints": {
      "primaryCount": 2,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 2
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 20,
    "complexityCategory": "Simple"
  },
  "collectionDate": "2025-09-22T05:06:11.776Z",
  "dataSource": "ClinicalTrials.gov API v2 - Ultimate Complete Collection"
}